购物车
- 全部删除
- 您的购物车当前为空
Setipiprant (ACT-129968) 是一种口服的选择性 CRTH2 拮抗剂,IC50为6.0 nM。
为众多的药物研发团队赋能,
让新药发现更简单!
Setipiprant (ACT-129968) 是一种口服的选择性 CRTH2 拮抗剂,IC50为6.0 nM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 228 | 现货 | |
10 mg | ¥ 328 | 现货 | |
25 mg | ¥ 597 | 现货 | |
50 mg | ¥ 963 | 现货 | |
100 mg | ¥ 1,430 | 现货 | |
200 mg | ¥ 2,130 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 253 | 现货 |
产品描述 | Setipiprant (ACT-129968) is an orally available, selective CRTH2 antagonist (IC50: 6.0 nM). CRTH2 is a G protein-coupled receptor for prostaglandin (PGD2). PGD2 is produced by the mast cells and is a key mediator in various inflammatory diseases, including allergy and asthma. Binding of PGD2 to CRTH2, which are expressed on the surface of blood-borne cells, induces chemotaxis of Th2 cells, basophils, and eosinophils, and stimulates cytokine release from these cells. |
靶点活性 | CRTH2:6.0 nM |
别名 | 塞替匹仑, KYTH-105, ACT-129968 |
分子量 | 402.42 |
分子式 | C24H19FN2O3 |
CAS No. | 866460-33-5 |
Smiles | C(C(O)=O)N1C2=C(C=3C1=CC=C(F)C3)CN(C(=O)C=4C5=C(C=CC4)C=CC=C5)CC2 |
密度 | 1.37 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 45 mg/mL (111.82 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容